Skip to main content

Animations

MJFF Publications

4631 - 4640 of 9118 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2026
  • 2025
  • 2023
  • 2024
  • 2024
  • 2025
  • 2023
  • 2026
  • Summary Details
    OPEN
    Title: From rodents to humans: Conserved codistribution of dopaminergic with serotonergic neurons in the dorsal raphe nucleus and their molecular characterization
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.107173
    Citation Count: 0
  • Cropland associated with risk of Parkinson's disease in the northern Great Plains
    2025
    Summary Details
    RESTRICTED
    Title: Cropland associated with risk of Parkinson's disease in the northern Great Plains
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107288
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Prediction of impulse control disorders in Parkinson’s disease through a longitudinal machine learning study
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01248-w
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A common mechanism of singular gene choice is revealed by broadly expressed odorant receptor transgenes within the olfactory epithelium
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.115955
    Citation Count: 3
  • Targeting LRRK2 mRNA stability in Parkinson’s disease
    2023
    Summary Details
    RESTRICTED
    Title: Targeting LRRK2 mRNA stability in Parkinson’s disease
    Journal Name: Trends in Neurosciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.tins.2023.10.003
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorder
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2024.105065
    Citation Count: 12
  • The angiotensin (1–7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation
    2024
    Summary Details
    RESTRICTED
    Title: The angiotensin (1–7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114926
    Citation Count: 13
  • Summary Details
    OPEN
    Title: The interplay between stress, inflammation and Parkinson’s disease: insights from the COVID-19 pandemic
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01178-7
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad192
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Development of cannabinoid-based therapies for Parkinson’s disease: emphasis on targeting cannabinoid receptors as CB2, PPAR-γ and GPR55 receptors
    Journal Name: Molecular Neurodegeneration Advances
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s44477-025-00016-7
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.